In the past year, the introduction of sanitary measures to counter COVID-19, such as wearing a mask, has limited the spread of other infections such as the common cold, sore throat and ear infections.
–
–
XTRA is a section that groups together promotional content produced by or for advertisers.
–
Although the lifting of certain health restrictions in daycares and schools this fall is greeted as a breath of fresh air, the absence of masks and the prolonged contact between the children foreshadows an upsurge in small seasonal ailments – remember that a child can easily get three to eight respiratory tract infections such as the common cold each year1. This is why Pharmascience launches HelixiaMD Enfants Natural DefenseMD, the only syrup offering proactive protection for children aged 3 to 10 against colds, sore throats and ear infections.
–
Proactive and secure
Despite all the benefits that schooling brings to children, several studies show that attending a daycare or school results in a higher exposure to recurrent upper respiratory tract infections, such as colds and sore throats, and increases the risk of developing an ear infection. In fact, the likelihood of catching an ear infection is 2.45 times greater in children who attend daycare than in those who stay at home, according to a meta-analysis in the medical journal. Clinical Infectious Diseases2.
In this context of return to normal, Helixia syrupMD Enfants Natural DefenseMD comes to us at the right time, because it helps prepare children to face the little ailments that run in daycare and school. From the same manufacturer as Prospan by Helixia cough syrups, this internationally proven product is clinically proven to prevent and reduce the frequency of colds, sore throats and ear infections.
–
To ensure protection for children from 3 to 10 years old, HelixiaMD Enfants Natural DefenseMD is a treatment to be incorporated into the morning routine from September, even before the onset of symptoms. In clinical studies, its effectiveness has reduced colds by more than 40% and ear infections by nearly 60%.3. Daily use for three to six months has also been shown to be safe.4.
From natural sources, this product contains pleuran, a beta-glucan extracted from oyster mushrooms (Pleurotus ostreastus) known for its effects in preventing recurrent upper respiratory infections. Plus, it’s free from sucrose, alcohol, colors, gluten, and artificial sweeteners.
–
Include prevention in your routine
The events of the past few months have reminded everyone of the importance of prevention when it comes to protecting loved ones. Combined with basic rules of hygiene, the daily intake of HelixiaMD Enfants Natural DefenseMD constitutes the best protection against these small ailments which sometimes give great worries. Easy to include in your morning routine, this treatment will prevent children from missing daycare or school and parents from having to take time off from work.
By adding it in the fall to her child’s morning routine before high cold season, HelixiaMD Enfants Natural DefenseMD will give each mom and dad the feeling that they have done everything in their power to protect their health and that they are doing a good thing for the community, since it will result in a reduction in the chain of transmission of these virus in winter.
HelixiaMD Enfants Natural DefenseMD has been available for a few weeks in all pharmacies in Quebec.
Find out more about Helixia syrupMD Enfants Natural DefenseMD
1 THOMAS, Eleanor M. 2010. “Recent Trends in Upper Respiratory Tract Infections, Ear Infections and Asthma in Young Children in Canada”, Health reports, flight. 21, nO 4, November, product nO Statistics Canada Catalog 82-003-X, p. 1 and 2.
2 https://pubmed.ncbi.nlm.nih.gov/8783714/
3 GRAU, J. Sapena, L. Picó SIRVENT, M. Morera INGLÉS and M. Rivero URGELL. 2015. «Beta-glucans from Pleurotus ostreatus for prevention of recurrent respiratory tract infections », Acta Pediatrica Espanola, vol. 73(8), p. 186 -193.
4 JESENAK, Milos, Juraj MAJTAN, Zuzana RENNEROVA, Jan KYSELOVIC, Peter BANOVCIN and Martin HRUBISKO. 2013. «Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections », International Immunopharmacology, vol. 15(2), p. 398.
–
